Epilepsy

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

4 hours ago   |   Xconomy

Perhaps the most talked-about news at the JP Morgan Healthcare Conference this week was a new startup that launched with $200 million and an ambitious claim its first drug...
Read more ...

Neurocrine, in Second Epilepsy Deal, Pairs With Swiss Biotech Idorsia

Neurocrine, in Second Epilepsy Deal, Pairs With Swiss Biotech Idorsia

6 days ago   |   Xconomy

Neurocrine is doubling down on epilepsy, striking its second agreement in as many months with a new deal that grants it the option to license an investigational treatment for a...
Read more ...

Behind the Seizure® Program Further Expands Access to Genetic Testing for Children to Speed the Diagnosis of Genetic Epilepsy

9 days ago   |   San Diego Biotechnology

Biogen, Encoded Therapeutics, Neurogene, Praxis Precision Medicines and PTC Therapeutics join founders BioMarin and Invitae to expand access for children under eight...
Read more ...

A novel IRF2BPL truncating variant is associated with endolysosomal storage

25 days ago   |   Springer

Abstract De novo mutations in the IRF2BPL gene have been identified to date in 18 patients presenting with neuromotor regression, epilepsy and variable neurological signs...
Read more ...

Customized multigene panels in epilepsy: the best things come in small packages

1 month ago   |   Springer

Abstract Over the past 10 years, the increasingly important role played by next-generation sequencing panels in the genetic diagnosis of epilepsy has led to a growing list of...
Read more ...

Extracellular Vesicles in the Forebrain Display Reduced miR-346 and miR-331-3p in a Rat Model of Chronic Temporal Lobe Epilepsy

1 month ago   |   Springer

Abstract An initial precipitating injury in the brain, such as after status epilepticus , evolves into chronic temporal lobe epilepsy. We investigated changes in the miRNA...
Read more ...

Identification of common genetic markers of paroxysmal neurological disorders using a network analysis approach

1 month ago   |   Springer

Abstract Emerging data have established links between paroxysmal neurological disorders or psychiatric disorder, such as migraine, ataxia, movement disorders and epilepsy...
Read more ...

Reactive Glia-Derived Neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age

1 month ago   |   Springer

Abstract Lafora disease is a rare, fatal form of progressive myoclonus epilepsy. The molecular basis of this devastating disease is still poorly understood, and no treatment is...
Read more ...

Neurocrine Bio takes aim at epilepsy with $50 million acquisiton

1 month ago   |   San Diego Biotechnology   |   2 articles

Collaboration with Xenon Pharmaceuticals seeks to commercialize treatment for the disease...
Read more ...

Neurocrine Inks $50M Xenon Pharma Deal to Expand Into Epilepsy

Neurocrine Inks $50M Xenon Pharma Deal to Expand Into Epilepsy

1 month ago   |   Xconomy   |   2 articles

Neurocrine Biosciences is paying $30 million cash and taking a $20 million equity stake in Xenon Pharmaceuticals to license a clinical-stage epilepsy drug and collaborate on...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Perhaps the most talked-about news at the JP Morgan Healthcare Conference this week was a new startup that launched with $200 million and an ambitious claim its first drug... Read more ...

Trending News on Crop Biotech in 2019

Trending News on Crop Biotech in 2019

We summarized the top 10 most trending Crop Biotech Update news shared on social media to give you a glimpse of crop biotech happenings in 2019. Read on and make sure you don't... Read more ...

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

Neon Therapeutics closed 2019 by curtailing its cancer vaccine programs and laying off 24 percent of its workforce, part of a corporate restructuring aimed at finding a new... Read more ...

Event Announcement: Xcelerating Life Sciences San Diego

Event Announcement: Xcelerating Life Sciences San Diego

We're excited to announce the first in Xconomy's new Xcelerating Life Sciences event series convening local communities of innovators, executives, rising pioneers... Read more ...

Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference

Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference

Startup nference has closed a $60 million Series B financing round to expand the use of its augmented intelligence platform in clinical research and drug development. Mayo... Read more ...

How Breast Cancer Reunited Six High School Friends

How Breast Cancer Reunited Six High School Friends

Four of the six of us from my high school inner circle have had breast cancer over the past two years. And that has me wondering. Did a shared environmental exposure, stamped... Read more ...

Stepping into their own

Stepping into their own

Two Bond Life Sciences Center researchers find their path in teaching and research Sarah Unruh and Vinit Shanbhag have both taken paths that have led them toward teaching... Read more ...

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

Emendo Biotherapeutics, a company aiming to apply CRISPR gene editing to a wider range of genetic diseases, has raised $61 million in financing. The Series B round was led by... Read more ...

103395 Biorepository Assistant

CANCER CENTER/ Solid Tumor Therapeutics Salary commensurate with qualifications and experienceFiling Deadline: Fri 1/31/2020... Read more ...

Quantitative visualization of subcellular lignocellulose revealing the...

As a renewable carbon source, biomass energy not only helps in resolving the management problems of lignocellulosic wastes, but also helps to alleviate the global climate... Read more ...